Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Oncology Reports|May 13, 2017
Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteinsRokas Račkauskas, Dachen Zhou, Simonas Ūselis, et al.Oncology Reports|April 5, 2024
[Retracted] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteinsRokas Račkauskas, Dachen Zhou, Simonas Ūselis, et al.American Journal of Surgery|June 12, 2010
Stapler vs suture closure of pancreatic remnant after distal pancreatectomy: a meta-analysisWei Zhou, Ran Lv, Xianfa Wang, et al.Oncoimmunology|August 31, 2012
Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancerIngrid Herr, Ariane Groth, Alexei V Salnikov, et al.International Immunology|September 6, 2012
Nitric oxide and glucocorticoids synergize in inducing apoptosis of CD4⁺8⁺ thymocytes: implications for 'Death by Neglect' and T-cell functionOrly Cohen, Eliran Ish-Shalom, Shlomit Kfir-Erenfeld, et al.Oncology Reports|October 13, 2023
[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteinsRokas Račkauskas, Dachen Zhou, Simonas Ūselis, et al.International Journal of Oncology|May 4, 2011
Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancerPatrick Naumann, Franco Fortunato, Hanswalter Zentgraf, et al.Trials|June 5, 2014
Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trialVladimir J Lozanovski, Philipp Houben, Ulf Hinz, et al.International Journal of Cancer|August 14, 2009
CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patientsAlexei V Salnikov, Jury Gladkich, Gerhard Moldenhauer, et al.Journal of the National Cancer Institute|March 30, 2012
Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinomaGerhard Moldenhauer, Alexei V Salnikov, Sandra Lüttgau, et al.Pageof 11